You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

POLYMYXIN B SULFATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Polymyxin B Sulfate patents expire, and what generic alternatives are available?

Polymyxin B Sulfate is a drug marketed by Adrastea Pharma, Eugia Pharma, Fresenius Kabi Usa, Gland, Hikma, Rising, Xellia Pharms Aps, and Paddock Llc. and is included in eight NDAs.

The generic ingredient in POLYMYXIN B SULFATE is polymyxin b sulfate. There are twelve drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the polymyxin b sulfate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Polymyxin B Sulfate

A generic version of POLYMYXIN B SULFATE was approved as polymyxin b sulfate by ADRASTEA PHARMA on September 30th, 1994.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for POLYMYXIN B SULFATE?
  • What are the global sales for POLYMYXIN B SULFATE?
  • What is Average Wholesale Price for POLYMYXIN B SULFATE?
Summary for POLYMYXIN B SULFATE
Drug patent expirations by year for POLYMYXIN B SULFATE
Recent Clinical Trials for POLYMYXIN B SULFATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Madonna Magdy FahmyEarly Phase 1
University of MiamiN/A
Bascom Palmer Eye InstituteN/A

See all POLYMYXIN B SULFATE clinical trials

Pharmacology for POLYMYXIN B SULFATE
Medical Subject Heading (MeSH) Categories for POLYMYXIN B SULFATE

US Patents and Regulatory Information for POLYMYXIN B SULFATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Adrastea Pharma POLYMYXIN B SULFATE polymyxin b sulfate INJECTABLE;INJECTION 063000-001 Sep 30, 1994 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Xellia Pharms Aps POLYMYXIN B SULFATE polymyxin b sulfate INJECTABLE;INJECTION 202766-001 Jan 15, 2014 AP RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Gland POLYMYXIN B SULFATE polymyxin b sulfate INJECTABLE;INJECTION 207322-001 Apr 14, 2016 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Paddock Llc POLYMYXIN B SULFATE polymyxin b sulfate POWDER;FOR RX COMPOUNDING 062455-001 Jul 27, 1983 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Eugia Pharma POLYMYXIN B SULFATE polymyxin b sulfate INJECTABLE;INJECTION 206589-001 Apr 4, 2016 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Fresenius Kabi Usa POLYMYXIN B SULFATE polymyxin b sulfate INJECTABLE;INJECTION 065372-001 Jan 10, 2008 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Rising POLYMYXIN B SULFATE polymyxin b sulfate INJECTABLE;INJECTION 090110-001 Jun 29, 2011 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.